AbCellera Biologics Inc.ABCLNASDAQ
Loading
EBITDA as a percentage of revenue
Percentile
P29
Within normal range
vs 5Y Ago
-2.8x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -206.88% | +70.8% |
| 2024 | -708.04% | -40.1% |
| 2023 | -505.35% | -1042.9% |
| 2022 | 53.60% | -15.9% |
| 2021 | 63.74% | -12.4% |
| 2020 | 72.75% | +5550.0% |
| 2019 | -1.33% | -108.2% |
| 2018 | 16.29% | - |